Haleon PLC closed 6.80% below its 52-week high of £4.18, which the company reached on March 4th.
In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline ...
Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...
Haleon Pakistan Limited has announced its first international shipment of locally manufactured Centrum multivitamins to Kenya ...
Hsbc Global Res lowered shares of Haleon (NYSE:HLN – Free Report) from a strong-buy rating to a hold rating in a research ...
Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...
Haleon HLN-1.12%decrease; red down pointing triangle posted a higher pretax profit for 2024 despite lower revenue, and said it expected further organic revenue and profit growth this year.
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...
HSBC analyst Jeremy Fialko downgraded Haleon (HLN) to Hold from Buy with a 420 GBp price target Discover the Best Stocks and Maximize Your ...
Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.
Berenberg Bank analyst Bethan Davies reiterated a Buy rating on Haleon PLC (HLN – Research Report) on February 28 and set a price target of ...
Haleon PLC HLN shares slipped 3.31% to £3.82 Thursday, on what proved to be an all-around favorable trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results